Back

Distilling the clinical evidence behind the WCD - What have clinical trials and registries told us?

18 March 2019 (12:50 - 13:05)
Organised by:
Congress Presentation Part of: Who should receive the Wearable Cardioverter Defibrillator (WCD)? Evidence and risk stratification for prevention of sudden cardiac death Prevention EHRA Premium Access EHRA 2019

About the speaker

Photo
Doctor Sebastian Reif

German Heart Center of Munich, Munich (Germany)

4 More presentations in this session

Presentation thumbnail
Introduction - Who should receive the Wearable Cardioverter Defibrillator (WCD)? Evidence and risk stratification for prevention of sudden cardiac death.
Doctor G. Botto (Garbagnate Milanese, IT)
Slides Video
Presentation thumbnail
Strategies for screening and identifying which patients to protect with the WCD.
Professor J. Ehrlich (Wiesbaden, DE)
Slides Video
Presentation thumbnail
The impact of the WCD for patients who choose to wear it.
Professor D. Scherr (Graz, AT)
Slides Video
Presentation thumbnail
Panel discussion and summary - Who should receive the Wearable Cardioverter Defibrillator (WCD)? Evidence and risk stratification for prevention of sudden cardiac death.
Doctor O. Piot (Saint-Denis, FR)
Slides Video

Access the full session

Session thumbnail
Who should receive the Wearable Cardioverter Defibrillator (WCD)? Evidence and risk stratification for prevention of sudden cardiac death

The Event

Event poster

EHRA 2019

18 March 2019 12:50 CET
You may be interested in
thumbnail
Congress Presentation
Wearable cardioverter defibrillator after ICD-system explantation: data from a multicenter registry
28 August 2023
thumbnail
Webinar
Registries to support implementation of care and trial design in heart failure
15 February 2022
thumbnail
Congress Session
Implantable cardioverter defibrillator therapy
31 August 2024
thumbnail
Webinar
Focus on percutaneous short-term ventricular assist devices: joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices - Part 1. Why, how and when percutaneous ventricular assist device support?
28 January 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources